ArticleAmerican journal of translational research2024
Interventional surgery shows efficacy for diabetic patients withperipheral vascular disease.
Article in American journal of translational research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo analyze the effect of interventional surgery on treatment efficacy and inflammatory cytokine (ICK) levels in diabetic patients with peripheral vascular disease (PVD).
methodsA total of 116 diabetic patients with PVD admitted to the Second Affiliated Hospital of Guangzhou Medical University from August 2020 to March 2022 were selected for this retrospective analysis. Patients were divided into two groups: 58 patients receiving conventional medication were assigned to the control group, while 58 patients receiving interventional surgery in addition to conventional medication were assigned to the research group. Comparative analyses were conducted based on clinical efficacy, symptom relief (limb pain, numbness, intermittent claudication, and coldness), ankle-brachial index (ABI) scores, vascular endothelial growth factor (VEGF), transforming growth factor-β (TGF-β), arterial inner diameter, and ICK levels.
resultsThe research group demonstrated a significantly higher overall effective rate compared to the control group, with markedly higher ABI scores, faster symptom resolution, increased VEGF and TGF-β levels, greater arterial diameters, and lower ICK levels.
conclusionInterventional surgery provides superior outcomes compared to conventional medication for treating diabetic patients with PVD, offering greater benefits in terms of ABI improvement, symptom relief, vascular factors, arterial diameter expansion, and ICK reduction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.